Published on in Vol 4 , No 10 (2020) :October

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/17898, first published .
Follow-Up of Cancer Patients Receiving Anti-PD-(L)1 Therapy Using an Electronic Patient-Reported Outcomes Tool (KISS): Prospective Feasibility Cohort Study

Follow-Up of Cancer Patients Receiving Anti-PD-(L)1 Therapy Using an Electronic Patient-Reported Outcomes Tool (KISS): Prospective Feasibility Cohort Study

Follow-Up of Cancer Patients Receiving Anti-PD-(L)1 Therapy Using an Electronic Patient-Reported Outcomes Tool (KISS): Prospective Feasibility Cohort Study

Journals

  1. Iivanainen S, Ekstrom J, Virtanen H, Kataja V, Koivunen J. Electronic patient-reported outcomes and machine learning in predicting immune-related adverse events of immune checkpoint inhibitor therapies. BMC Medical Informatics and Decision Making 2021;21(1) View
  2. Sauer C, Krauß J, Jäger D, Zschäbitz S, Haag G, Walle T, Sauer S, Kiermeier S, Friederich H, Maatouk I. eHealth intervention to manage symptoms for patients with cancer on immunotherapy (SOFIA): a study protocol for a randomised controlled external pilot trial. BMJ Open 2021;11(7):e047277 View
  3. Denis F, Krakowski I. Which Electronic Patient’s Reported Outcome System should I choose for Remote Monitoring of my Cancer Patients? (Preprint). Journal of Medical Internet Research 2021 View